These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 24461673)

  • 1. Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP).
    Ronaghy A; Streilein RD; Hall RP
    J Dermatol Sci; 2014 Apr; 74(1):93-4. PubMed ID: 24461673
    [No Abstract]   [Full Text] [Related]  

  • 2. Case of subepidermal bullous disease with diffuse esophageal involvement presenting with immunoglobulin G autoantibodies to both the BP180 NC16a and C-terminal domains, and immunoglobulin A autoantibodies to the BP180 NC16a domain.
    Takayama N; Nakazono S; Kumagai J; Kawamura T; Suzuki F; Ishii N; Hashimoto T; Namiki T
    J Dermatol; 2014 Jul; 41(7):665-7. PubMed ID: 24930476
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlation of IgE autoantibody to BP180 with a severe form of bullous pemphigoid.
    Iwata Y; Komura K; Kodera M; Usuda T; Yokoyama Y; Hara T; Muroi E; Ogawa F; Takenaka M; Sato S
    Arch Dermatol; 2008 Jan; 144(1):41-8. PubMed ID: 18209167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
    Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
    J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum levels of immunoglobulins G1 and G4 targeting the non-collagenous 16A domain of BP180 reflect bullous pemphigoid activity and predict bad prognosis.
    Zhou XP; Liu B; Xu Q; Yang Y; He CX; Zuo YG; Liu YH
    J Dermatol; 2016 Feb; 43(2):141-8. PubMed ID: 26300465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
    Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
    Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of vancomycin-induced linear IgA bullous dermatosis with circulating IgA antibodies to the NC16a domain of BP180.
    Tashima S; Konishi K; Koga H; Hashimoto T
    Int J Dermatol; 2014 Mar; 53(3):e207-9. PubMed ID: 23829415
    [No Abstract]   [Full Text] [Related]  

  • 8. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
    Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
    J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
    Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C
    Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180.
    Nie Z; Nagata Y; Joubeh S; Hirako Y; Owaribe K; Kitajima Y; Hashimoto T
    J Invest Dermatol; 2000 Dec; 115(6):1164-6. PubMed ID: 11121162
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG from patients with bullous pemphigoid depletes cultured keratinocytes of the 180-kDa bullous pemphigoid antigen (type XVII collagen) and weakens cell attachment.
    Iwata H; Kamio N; Aoyama Y; Yamamoto Y; Hirako Y; Owaribe K; Kitajima Y
    J Invest Dermatol; 2009 Apr; 129(4):919-26. PubMed ID: 19177144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses.
    Laffitte E; Skaria M; Jaunin F; Tamm K; Saurat JH; Favre B; Borradori L
    Br J Dermatol; 2001 Apr; 144(4):760-8. PubMed ID: 11298534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of childhood bullous pemphigoid with IgG and IgA autoantibodies to various domains of BP180.
    Osawa M; Ueda-Hayakawa I; Isei T; Yoshimura K; Fukuda S; Hashimoto T; Okamoto H
    J Am Acad Dermatol; 2014 Jun; 70(6):e129-31. PubMed ID: 24831331
    [No Abstract]   [Full Text] [Related]  

  • 14. BP230- and BP180-specific auto-antibodies in bullous pemphigoid.
    Thoma-Uszynski S; Uter W; Schwietzke S; Hofmann SC; Hunziker T; Bernard P; Treudler R; Zouboulis CC; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2004 Jun; 122(6):1413-22. PubMed ID: 15175032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgG anti-LABD97 antibodies in bullous pemphigoid patients' sera react with the mid-portion of the BPAg2 ectodomain.
    Egan CA; Reddy D; Nie Z; Taylor TB; Schmidt LA; Meyer LJ; Petersen MJ; Hashimoto T; Marinkovich MP; Zone JJ
    J Invest Dermatol; 2001 Feb; 116(2):348-50. PubMed ID: 11180014
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system.
    Pomponi D; Di Zenzo G; Zennaro D; Calabresi V; Eming R; Zuzzi S; Bernardi ML; Scala E; Mari A
    Br J Dermatol; 2013 Jun; 168(6):1205-14. PubMed ID: 23252883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.
    Kamiya K; Aoyama Y; Noda K; Miyake T; Yamaguchi M; Hamada T; Tokura Y; Iwatsuki K
    J Dermatol Sci; 2015 Apr; 78(1):77-9. PubMed ID: 25771164
    [No Abstract]   [Full Text] [Related]  

  • 19. Bullous pemphigoid IgG induces BP180 internalization via a macropinocytic pathway.
    Hiroyasu S; Ozawa T; Kobayashi H; Ishii M; Aoyama Y; Kitajima Y; Hashimoto T; Jones JC; Tsuruta D
    Am J Pathol; 2013 Mar; 182(3):828-40. PubMed ID: 23337823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel fluctuation of anti-desmoglein 3 and anti-BP180 autoantibody titres in a patient with bullous pemphigoid.
    Takahashi H; Anzai H; Suzuki Y; Tanikawa A; Amagai M; Nishikawa T
    Clin Exp Dermatol; 2004 Nov; 29(6):608-11. PubMed ID: 15550133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.